MicroRNA-26a inhibits proliferation by targeting high mobility group AT-hook 1 in breast cancer

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 1, 2015, Pages 368-373

  Zhao, Xi Xue ^a   Yuan, Qing Zhong ^a   Mu, Dong Po ^a   Sun, Di Wen ^a   Bo, Qing Ao ^a   Pan, Guo Zheng ^a   Li, Guo Qiang ^a   Cui, Tao ^a   Ding, Peng Peng ^a   You, Fa Ping ^a   Hao, Long ^a   Wang, Ming Xin ^a   Zhang, Jian ^a  

^a Department of Hepatobiliary and Breast Surgery Shengli Oilfield Central Hospital ^*  (China)

Author keywords

Breast cancer; HMGA1; MiR 26a; Proliferation

Indexed keywords

HIGH MOBILITY GROUP A PROTEIN; MICRORNA; MIRN26A MICRORNA, HUMAN;

BIOSYNTHESIS; BREAST TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGA PROTEINS; HUMANS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84923112942     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin 2014; 64: 104-17.
2. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-97.
3. Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell 2009; 136: 586-91.
4. Schickel R, Boyerinas B, Park SM, Peter ME. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008; 27: 5959-74.
5. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-66.
6. Yu L, Lu J, Zhang B, Liu X, Wang L, Li SY, Peng XH, Xu X, Tian WD, Li XP. miR-26a inhibits invasion and metastasis of nasopharyngeal cancer by targeting EZH2. Oncol Lett 2013; 5: 1223-28.
7. Chen L, Zheng J, Zhang Y, Yang L, Wang J, Ni J, Cui D, Yu C, Cai Z. Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways. Mol Ther 2011; 19: 1521-8.
8. Lu J, He ML, Wang L, Chen Y, Liu X, Dong Q, Chen YC, Peng Y, Yao KT, Kung HF, Li XP. MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2. Cancer Res 2011; 71: 225-33.
9. Liu B, Wu X, Liu B, Wang C, Liu Y, Zhou Q, Xu K. MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Biochim Biophys Acta 2012; 1822: 1692-704.
10. Zhang J, Han C, Wu T. MicroRNA-26a promotes cholangiocarcinoma growth by activating beta-catenin. Gastroenterology 2012; 143: 246-56 e8.
11. Huse JT, Brennan C, Hambardzumyan D, Wee B, Pena J, Rouhanifard SH, Sohn-Lee C, le Sa-ge C, Agami R, Tuschl T, Holland EC. The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes Dev 2009; 23: 1327-37.
12. Shah SN, Resar LM. High mobility group A1 and cancer: potential biomarker and therapeutic target. Histol Histopathol 2012; 27: 567-79.
13. Fusco A, Fedele M. Roles of HMGA proteins in cancer. Nat Rev Cancer 2007; 7: 899-910.
14. Fedele M, Fusco A. HMGA and cancer. Biochim Biophys Acta 2010; 1799: 48-54.
15. Di Cello F, Shin J, Harbom K, Brayton C. Kno-ckdown of HMGA1 inhibits human breast cancer cell growth and metastasis in immunodeficient mice. Biochem Biophys Res Commun 2013; 434: 70-4.
16. Early Breast Cancer Trialists' Collaborative G. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the rando-mised trials. Lancet 2005; 365: 1687-717.
17. Paplomata E, O'Regan R. The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers. Ther Adv Med Oncol 2014; 6: 154-66.
18. Zhang W, Liu J, Wang G. The role of microRNAs in human breast cancer progression. Tumour Biol 2014; 35: 6235-44.
19. Lin Y, Chen H, Hu Z, Mao Y, Xu X, Zhu Y, Xu X, Wu J, Li S, Mao Q, Zheng X, Xie L. miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1. FEBS Lett 2013; 587: 2467-73.